A study led by Case Western Reserve University School of Medicine, in collaboration with the University of East London UK, and Swansea University UK, is the first to show the effects of the drug ...
Add Yahoo as a preferred source to see more of our stories on Google. The research that the FDA considered was spearheaded by the Multidisciplinary Association for Psychedelic Studies (MAPS), which ...
Only two drugs are formally approved for post-traumatic stress disorder, or PTSD, and they don’t help everyone. A lack of effective treatment options has led some patients to seek out the psychedelic ...
Add Yahoo as a preferred source to see more of our stories on Google. This photo provided by the Center for Psychedelic Therapy Research shows a Yehuda Lab MDMA-assisted therapy treatment room at the ...
Efforts to make MDMA legally available as a psychotherapeutic catalyst hit a daunting roadblock on Tuesday when an expert panel overwhelmingly voted to recommend that the Food and Drug Administration ...
FDA staff raised concerns about the available safety data and limitations in the study design for midomafetamine (MDMA) to treat post-traumatic stress disorder (PTSD) in briefing documents released ...
Ahead of a key meeting Tuesday to weigh the potential approval of midomafetamine, or MDMA, for patients with post-traumatic stress disorder, the Food and Drug Administration is proposing a new set of ...
Use of the drug MDMA, commonly known as ecstasy, may lead to lasting difficulties with learning and memory that persist long after a person stops taking it. A new analysis indicates that people who ...
Often used at dance clubs and concerts, the recreational drug known as ecstasy (MDMA) is dangerous and, in some cases, may even prove deadly (1-2). Even so, a growing body of evidence shows that, in ...
MDMA (3,4-methylenedioxymethamphetamine), known colloquially as Molly and Ecstasy, is a synthetic drug with effects similar to stimulants like methamphetamine. It was first synthesized in 1912 by ...
Mind Medicine (MindMed) Inc. (MNMD) is a biotech that should be on everyone's watch list. The reason why I state this is that it has been able to make substantial improvements in the MDMA treatment ...
When the Food and Drug Administration (FDA) declined to approve MDMA-assisted psychotherapy as a treatment for post-traumatic stress disorder (PTSD) last year, the details of its objections were not ...